Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment
Latest Information Update: 04 Jun 2024
At a glance
- Drugs Pentoxifylline (Primary) ; Tocopherol (Primary)
- Indications Osteonecrosis
- Focus Therapeutic Use
- 30 May 2024 Planned End Date changed from 30 Jun 2025 to 30 Jun 2026.
- 30 May 2024 Planned primary completion date changed from 1 Jan 2025 to 1 Jan 2026.
- 26 Apr 2022 Planned End Date changed from 1 Jan 2023 to 30 Jun 2025.